High flow nasal therapy in immunocompromised patients with acute respiratory failure: A systematic review and meta-analysis.

Cannula Critical Care Humans Immunocompromised Host Intubation, Intratracheal / instrumentation Noninvasive Ventilation / instrumentation Oxygen Inhalation Therapy / instrumentation Randomized Controlled Trials as Topic Respiratory Distress Syndrome / therapy
Acute respiratory failure High flow nasal cannula High flow nasal therapy Immunocompromised patients Mechanical ventilation Noninvasive ventilation Oxygen therapy

Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 11 2018
revised: 27 12 2018
accepted: 27 12 2018
pubmed: 10 1 2019
medline: 23 5 2020
entrez: 10 1 2019
Statut: ppublish

Résumé

The role of high-flow nasal therapy (HFNT) as compared to conventional oxygen therapy (COT) in immunocompromised patients admitted to intensive care unit (ICU) with acute respiratory failure (ARF) remains unclear. We conducted a systematic review and meta-analysis in order to address this issue. We searched PubMed, Medline and Embase until November 7th, 2018. Randomized controlled trials (RCTs), non-randomized prospective and retrospective evidence were selected. Observational studies were considered for sensitivity analysis. Primary outcome was mortality rate; intubation rate was a secondary outcome. We included four studies in the primary analysis: one RCT, two RCT's post-hoc analyses and one retrospective study. We found no significant difference in short-term mortality comparing HFNT vs. COT: 1) ICU: n = 872 patients, odds ratio (OR) = 0.80 [0.44,1.45], p = 0.46, I We found no benefit of HFNT over COT on mortality in immunocompromised patients with ARF. However, HFNT was associated with a lower intubation rate warranting further research.

Identifiants

DOI: 10.1016/j.jcrc.2018.12.015 PMID: 30622042
pubmed: 30622042
pii: S0883-9441(18)31675-7
doi: 10.1016/j.jcrc.2018.12.015
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

250-256

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Andrea Cortegiani (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy. Electronic address: andrea.cortegiani@unipa.it.

Claudia Crimi (C)

Respiratory Medicine Unit, AOU "Policlinico-Vittorio Emanuele", Catania, Italy.

Filippo Sanfilippo (F)

Department of Anesthesia and Intensive Care, AOU Policlinico Vittorio Emanuele, Catania, Italy.

Alberto Noto (A)

Anesthesia and Intensive Care Unit, AOU Policinico "G. Martino", Messina, Italy.

Davide Di Falco (D)

Department of Anesthesia and Intensive Care, School of Anesthesia and Intensive Care, University of Catania, 95100 Catania, Italy.

Giacomo Grasselli (G)

Department of Anesthesiology, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Via Festa del Perdono 1, 20122, Milan, Italy.

Cesare Gregoretti (C)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.

Antonino Giarratano (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Équipement et fournitures › Cathéters › Canule › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Soins de réanimation › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Phénomènes du système immunitaire › Sujet immunodéprimé › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Techniques d'investigation › Intubation › Intubation trachéale › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Thérapeutique › Thérapie respiratoire › Ventilation artificielle › Ventilation non effractive › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Thérapeutique › Thérapie respiratoire › Oxygénothérapie › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › High flow nasal therapy in immunocompromised...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Troubles respiratoires › Syndrome de détresse respiratoire de l'adulte › High flow nasal therapy in immunocompromised...